NASDAQ:BIOC - Biocept Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.00 0.00 (0.00 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$1.00
Today's Range$1.00 - $1.05
52-Week Range$0.66 - $12.30
Volume725,435 shs
Average Volume2.26 million shs
Market Capitalization$2.27 million
P/E Ratio-0.04
Dividend YieldN/A
Beta3.09

Analyst Ratings

Biocept (NASDAQ:BIOC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Biocept in the last 12 months. Their average twelve-month price target is $1.00, suggesting that the stock has a possible downside of 0.00%. The high price target for BIOC is $1.00 and the low price target for BIOC is $1.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.00$1.00$1.00$1.25
Price Target Upside: 0.00% downside60.16% downside60.16% downside594.44% upside

Biocept (NASDAQ:BIOC) Consensus Price Target History

Price Target History for Biocept (NASDAQ:BIOC)

Biocept (NASDAQ:BIOC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/3/2018Dawson JamesReiterated RatingBuyHighView Rating Details
5/23/2018Westpark CapitalDowngradeOutperform ➝ HoldLowView Rating Details
11/14/2017Chardan CapitalReiterated RatingBuy ➝ Buy$2.50 ➝ $1.50N/AView Rating Details
3/13/2017Roth CapitalReiterated RatingBuy$1.60 ➝ $3.00LowView Rating Details
(Data available from 2/23/2017 forward)
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel